Skip To Content
Fast Forward

Sheldon Adelson Treated For Cancer, In ‘Dire’ Health

Billionaire casino magnate and pro-Israel mega-donor Sheldon Adelson is being treated for cancer, Bloomberg reported.

Adelson, 85, has been out of his office since late December due to side-effects from his treatment for non-Hodgkin’s lymphoma. A lawyer representing one of Adelson’s casinos referred to his health as “dire” in court Monday.

A company spokesman told Bloomberg that Adelson’s illness has not kept him from acting as the chairman and CEO of the Las Vegas Sands Corp., Adelson’s casino empire. However, Adelson missed a call to investors in January.

Adelson is worth $39 billion, according to the Bloomberg Billionaire Index. He was the largest outside spender during the 2016 elections, and has donated hundreds of millions of dollars to Jewish and Israeli causes.

Ari Feldman is a staff writer at the Forward. Contact him at [email protected] or follow him on Twitter @aefeldman

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.